Auson
奥全生物
Auson
Biotech/Healthcare
Auson is an international biopharmaceutical services company focused on the R&D and commercialization of innovative drugs. It explores new treatment approaches, including novel formulations, dosing regimens, and indications, to develop 505(b)(2) drugs for FDA approval and Class 2 new drugs for NMPA…
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.